Oral Ganciclovir in the Prevention of Cytomegalovirus Infection in Postkidney Transplant “CMV at Risk” Recipients: A Controlled, Comparative Study of Two Regimens (750 mg Bid and 500 mg Bid) - Concepedia

Concepedia

Publication | Closed Access

Oral Ganciclovir in the Prevention of Cytomegalovirus Infection in Postkidney Transplant “CMV at Risk” Recipients: A Controlled, Comparative Study of Two Regimens (750 mg Bid and 500 mg Bid)

22

Citations

11

References

1998

Year

N Ahsan, Michael J. Holman, Lene Sonderbye, E Langhoff, H C Yang

Transplantation Proceedings

TransplantationImmunologyTransplantation MedicineAntiviral TherapyVirologyOral GanciclovirAntiviral DrugMedicineMg BidComparative Study

References

	Year	Citations

Page 1